Ghost Tree Capital, LLC Surface Oncology, Inc. Transaction History

Ghost Tree Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$7.25 - $13.82 $7.25 Million - $13.8 Million	-1,000,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $1.52 Million - $2.17 Million	300,000 Added 42.86%	1,000,000 $6.9 Million
Q2 2020 Aug 14, 2020	BUY	$1.57 - $6.56 $1.1 Million - $4.59 Million	700,000 New	700,000 $4.59 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.